Jefferson University Hospitals

Hereditary Breast Ovarian Cancer Syndrome

Related Content
  • Among the Nation's Best for Cancer
    Among the Nation's Best for Cancer
    U.S. News has named Jefferson among the best hospitals in the nation for Cancer care.
    Learn More >

The Jefferson Health Clinical Cancer Genetics Service offers risk assessment, genetic counseling and gene testing for hereditary breast and ovarian cancer syndrome. Through detailed genetics counseling, one of our genetic specialists will carefully evaluate your medical and family history and assess your risk for carrying a hereditary breast cancer trait.

Based on your degree of risk, genetic testing might be recommended. Genetic testing for BRCA1 and BRCA2 is now available. Since both BRCA1 and BRCA2 are very large genes, it is very expensive and time-consuming to study both genes completely. If your family is considering testing, it is best to first test a family member who has been diagnosed with cancer. If a mutation in either BRCA1 or BRCA2 exists in the family, it would most likely be identified in this individual.

With an emphasis on the early detection of cancer, physicians of Jefferson Health's Breast Care Center can help you manage the risk factors of hereditary breast and ovarian cancer syndrome and reduce the probability of developing cancer. If you are found to be at risk for developing cancer, our medical team can help you devise risk-management strategies that include regular cancer screening exams to help detect any existing cancers at their earliest, most treatable stages, as well as preventive surgery or medication therapy. Our Center physicians will also determine if you are eligible to participate in clinical research trials for new and experimental cancer prevention therapies.

The Jefferson Health Breast Care Center has full accreditation from the National Accreditation Program for Breast Cancers (NAPBC). Administered by the American College of Surgeons, the NAPBC recognizes centers that achieve the highest standards for breast cancer treatment in the areas of leadership, clinical management, research, community outreach, professional education and quality improvement.